Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-((2'-(1H-tetrazol-5-yl)bipohenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-((2'-(1H-tetrazol-5-yl)bipohenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine
Unique ID
C493912
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C493912
Entry Term(s)
(11C)KR31173
KR 31173
KR-31173
R31173
Registry Numbers
0
Heading Mapped to
*Imidazoles
*Tetrazoles
Frequency
7
Note
an angiotensin AT1 receptor ligand for PET imaging; structure in first source
Source
Nucl Med Biol 2004 Jul;31(5):571-4
Indexing Information
Carbon Radioisotopes
Ligands
Date of Entry
2004/12/11
Revision Date
2006/06/15
2-butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-((2'-(1H-tetrazol-5-yl)bipohenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine Preferred
KR 31173 Narrower
(11C)KR31173 Narrower
page delivered in 0.006s